Technical and Scientific Information
DSIP (delta sleep-inducing peptide) is a nonapeptide first described in the context of sleep research. Early studies explored its relationship with slow-wave sleep, neuroendocrine responses, and stress-associated signaling. Its mechanisms and reproducible effects in humans remain uncertain. Statements about sleep improvement, anxiety, hormonal changes, or recovery in historical materials are research claims rather than established clinical benefits. There is no validated dosing or administration protocol for this catalog research material.
